Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: Its role in dominant negative action

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1456-1463

  Zhu, X U Guang ^a   McPhie, Peter ^b   Cheng, Sheue Yann ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c MSC 4255 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIOTHYRONINE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; DIMERIZATION; DISSOCIATION; ELECTROPHORETIC MOBILITY; HORMONE RESPONSIVE ELEMENT; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THYROID HORMONE RESISTANCE;

EID: 0030960827     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5067     Document Type: Article

References (25)

1. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
2. Usala SJ 1995 New developments in clinical and genetic aspects of thyroid hormone resistance syndromes. The Endocrinologist 5:68-76
3. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub BD 1995 Genetic and clinical features of 42 kindreds with resistance to thyroid hormone:The NIH prospective study Ann Intern Med 123:625-627
4. Cheng S-y 1995 New insights into the structure and function of the thyroid hormone receptor. J Biomed Sci 2:77-89
5. Lin KH, Parkison C, McPhie P, Cheng SY 1991 An essential role of domain D in the hormone-binding activity of human β1 thyroid hormone nuclear receptor. Mol Endocrinol 5:485-492
6. Mangelsdorf DJ, Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83:841-850
7. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
8. Lin KH, Zhu XG, Shieh HY, Hsu HC, Chen ZT, McPhie P, Cheng S-y 1996 Identification of naturally occurring dominant negative mutants of thyroid hormone α1 and β1 receptors in a human hepatocellular carcinoma cell line. Endocrinology 137:4073-4081
9. 3 response element-dependent dominant negative potency. J Clin Invest 92:1986-1993
10. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB, Cheng SY, Weintraub BD 1992 Variable transcriptional activity and ligand binding of mutant β1 3,5,3′-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258
11. Yen P, Chin WW 1994 Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol Endocrinol 8:1450-1454
12. Meier-Heusler SC, Zhu XG, Juge-Aubry C, Pernin A, Burger AG, Cheng SY, Meier CA 1995 Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbAa2 and peroxisome proliferation-activated receptor: evidence for different mechanisms of inhibition. Mol Cell Endocrinol 107:35-66
13. Zhu XG, Yu CL, McPhie P, Wong R, and Cheng S-y 1996 Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone b1 receptors: the important role of the wild-type/mutant receptor heterodimer. Endocrinology 137:712-721
14. Lin KH, Lin YW, Parkison C, and Cheng S-y 1994 Stimulation of proliferation by 3,3′,5-triiodo-L-thyronine in poorly differentiated hyman hepatocarcinoma cells overexpressing β1 thyroid hormone receptor. Cancer Lett 85:189-194
15. Lin KH, Fukuda T, Cheng S-y 1990 Hormone and DNA binding activity of a purified thyroid hormone nuclear receptor expressed in Escherichia coli. J Biol Chem 265:5161-5165
16. 3-receptor / retinoid × receptor heterodimer binding to DNA. J Biol Chem 267:23248-23252
17. Darling DS, Carter RL, Yen PM, Welborn JM, Chin WW, Umeda PK 1943 Different dimerization activities of alpha and beta thyroid hormone receptor isoforms. J Biol Chem 268:10221-10227
18. Yen PM, Sugawara A, Refetoff S, Chin WW 1992 New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J Clin Invest 90:1825-1831
19. Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ 1990 Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Mol Endocrinol 4:1988-1994
20. Chatterjee VK, Nagaya T, Madison LD, Datta S, Rentoumis A, Jameson JL 1991 Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest 87:1977-1984
21. Hayashi Y, Janssen OE, Weiss RE, Murata Y, Seo H, Refetoff S 1993 The relative expression of mutant and normal thyroid hormone receptor genes in patients with generalized resistance to thyroid hormone determined by estimation of their specific messenger ribonucleic acid products. J Clin Endocrinol Metab 76:64-69
22. 3 receptor alleles in kindreds with generalized resistance to thyroid hormone. J Clin Invest 91:2296-2300
23. 3 receptor alleles in kindreds with generalized resistance to thyroid hormone. J Clin Invest 91:2296-300
24. Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH 1990 Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J Biol Chem 265:10514-10521
25. Schwartz HL, Strait KA, Ling NC, Oppenheimer JH 1992 Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J Biol Chem 267: 11794-11799